Caliway Biopharmaceuticals , Ltd. Current Cash

Caliway Biopharmaceuticals , Ltd. (6919.TWO) currently reports a current cash of $2.5B as of March 2026. That compares with $9.3B in the prior-year period — down 72.7% year over year. Use the charts on this page to explore Caliway Biopharmaceuticals , Ltd.'s current cash history and peer comparisons.

Caliway Biopharmaceuticals , Ltd.'s current cash decreased from $9.3B to $2.5B — a 72.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Caliway Biopharmaceuticals , Ltd. reported $2.5B in current cash as of March 2026. That compares with $9.3B in the prior-year period — down 72.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $2.5B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Caliway Biopharmaceuticals , Ltd., and consider following 6919.TWO for alerts when major investors trade the stock.

Caliway Biopharmaceuticals , Ltd. is classified in the Healthcare sector. On current cash, it currently shows $2.5B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6919.TWO with unrelated industries.